Deutsche Bank AG acquired a new stake in Baxter International Inc. (NYSE:BAX – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 2,071,642 shares of the medical instruments supplier’s stock, valued at approximately $44,167,000.
Other large investors have also recently bought and sold shares of the company. AMG National Trust Bank bought a new position in Baxter International during the second quarter valued at about $2,522,000. Geode Capital Management LLC boosted its stake in shares of Baxter International by 7.8% during the 4th quarter. Geode Capital Management LLC now owns 13,510,205 shares of the medical instruments supplier’s stock worth $257,174,000 after acquiring an additional 972,891 shares in the last quarter. Fiduciary Alliance LLC increased its holdings in shares of Baxter International by 95.6% during the 1st quarter. Fiduciary Alliance LLC now owns 258,062 shares of the medical instruments supplier’s stock valued at $4,542,000 after acquiring an additional 126,104 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of Baxter International during the 2nd quarter valued at about $14,064,000. Finally, Thompson Siegel & Walmsley LLC raised its stake in shares of Baxter International by 12.0% in the 4th quarter. Thompson Siegel & Walmsley LLC now owns 3,328,202 shares of the medical instruments supplier’s stock valued at $63,602,000 after acquiring an additional 356,612 shares in the last quarter. 90.19% of the stock is currently owned by institutional investors.
Baxter International Stock Down 0.2%
Shares of BAX stock opened at $26.37 on Friday. The stock has a market cap of $13.63 billion, a P/E ratio of -12.74, a price-to-earnings-growth ratio of 3.99 and a beta of 0.60. Baxter International Inc. has a one year low of $15.73 and a one year high of $30.00. The stock has a fifty day moving average price of $23.62 and a 200 day moving average price of $20.36. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.95 and a quick ratio of 1.32.
Baxter International Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Friday, August 28th will be paid a $0.01 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. Baxter International’s payout ratio is presently -1.93%.
Analyst Ratings Changes
Several research firms recently weighed in on BAX. Zacks Research upgraded Baxter International from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. Stifel Nicolaus lifted their price target on shares of Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Citigroup upgraded shares of Baxter International from a “sell” rating to a “neutral” rating and boosted their price objective for the stock from $17.00 to $28.00 in a research note on Friday, July 31st. TD Cowen upped their price objective on shares of Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a report on Monday, July 27th. Finally, The Goldman Sachs Group raised their target price on shares of Baxter International from $19.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, July 15th. Two equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Baxter International presently has a consensus rating of “Hold” and an average target price of $22.45.
Get Our Latest Research Report on Baxter International
Baxter International Company Profile
Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.
In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.
Read More
- Five stocks we like better than Baxter International
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.
